1. 1. 1 103 103 103 68 16 5,061 9,000 28 16 12 4,900 1,000 4 4,000 8 900 () 1 () 1 2,430 5,000 1. 1 2,430 5,000
2. 2. 2 (1). 2 (101 102 ) 137 7 (2). (3). 2 100 5,500 26 (CoChrane Library) (4). 2. 350 (1). (2). (3).
3. 3. 3 I. 2 (101 102 ) 50 36 II. (JFMA) 102 12 10 3. 103 () 1 () 8 7,927 9,000 1. (1). (2).
4. 4. 4 (3). (4). () 10%() 12% 2. 103 102 (WHO)(Health equity)
5. 5. 5 (1). I. (HTA) ( ) II. e-Health e-Health e-Health III.,GIS, LTC Data Bank (Ambient Assisted Living, AAL) (e-Health)
6. 6. 6 (2). I. 376 II. III. IV. V. VI. (3).
7. 7. 7 4 I. i. ii. iii. II. i. ii. iii. III. i. ii. iii. IV. i. ii. (4). I. II. III.
8. 8. 8 IV. (Open Data) V. 3. 103 () 1 () 8 7,927 9,000 1. 102 142 265 48
9. 9. 9 103 2. (1). (2). (3). 200 500 104 3. () 1 () 2 0,252 3,000 102 1. 103 102 (1). 102 4 (99-102) 1 4 (2). 103 3 (103-105) 1 3 PI-initiated 103
10. 10. 10 2. 102 970 386 322 PI 262 3. 103 102 103 () 1 () 1 0,773 6,000 1. 2. (HIS PACS)
11. 11. 11 3. ( ) - - 4. : (1). 102 4 (2). 102 142265 48 103 (3). : I.
12. 12. 12 II. 200 500 104 5. () 1 () 1 3,749 1,000 101 102 4 1. 102 4 2. 99 101 142 3. 102 102 142 265 48 103 4. 103
13. 13. 13 : (1). (2). 200 500 104 5. () 1 () 95 6,548 8,000 1. 27 19 49 103 102 2. 103 1,684 () 102 5 102 1 3 1,684 102 1 1
14. 14. 14 1 5 1,376 4 3. 102 4 36 1,765 6-7%103 38 7,873 103 6 44 7,873 1,376 103 73 9,527 9,000 103 8 4,105 8,000 7 4,892 2,000 102 5 103 5 4. 103 5 102 103
15. 15. 15 : () () 97 223,697 527,900 481,884 98 256,342 14.59% 572,349 8.42% 520,314 7.97% 99 273,361 6.64% 604,722 5.66% 543,696 4.49% 100 314,282 14.97% 648,367 7.22% 593,533 9.17% 101 357,436 13.73% 719,955 11.04% 646,423 8.91% 102-1 102-2 102-3 102-4 345,365 351,852 358,743 361,765 1.87% 1.95% 2.00% 766,648 6.49% 679,770 5.16% 97-101 12.48% 8.08% 7.64% :103 () () 102 () () 447,873 1,376 7,395,279 79,280 7,474,559 841,058 494,367 2,084,347 748,922 8,985,259 573,647 9,558,906 1. 103 6-7% 387,873 103 60,000 447,873 2. 1,376 3. 102 7,928 4.( 8.08 7.64) 5. 102 4 9,436 7,000
16. 16. 16 () 1 () 38,471 8,000 1. 97 8 18 () 3 1 1 5,252 101 5,834 2.6 2. 98 10 19 7 4 () () 98 11 3 3. 5 102 12 15 8,398
17. 17. 17 97 98 98 5 6,769 9 792 99 99 4. 102 11 8 2 5. 103 6. 103 () 1 () 9,991 9,000
18. 18. 18 1. 102 11 1 2. 102 11 8 12 3 3,394 324 33 103 1 14 3,800 3. (1). 9,286 6,000 7,351.4 33,333.15 ( 4.53 ) 450 1,100 ( 650 ) 700 1,500 ( 800 )
19. 19. 19 (2). 500 6,000 (3). 204 7,000 4. () 1 () 23 5,523 1,000 1. 102 2 26 2.3.7 102 4 23 102 103 104
20. 20. 20 2. (1). (2). (3). 3. () 1 () 23 5,523 1,000 1. 103 1 6 (1). 6 5,000 (2). 103 49 61 (59.2%) (3).
21. 21. 21 () (4). 2,200 100 28 97.1% (5). 5 6,000 14.2% 400 13.7%102 11 0.079 (6). (7). 4.89 31.5% (8). 9 (9). 103 3 5% 2. (1). I. II. 102 10 2
22. 22. 22 1021780248 III. (2). 102 10 23 1033 14 103 3. (1). 103 49 100% (2).
23. 23. 23 4. (1). I. 102 10 1 102 11 II. 102 12 III.102 12 24 2 103 1 20 IV. (103) 3 21 27 4 3 3
24. 24. 24 V. (2). I. 103 X BMI II. 5. 6.
25. 25. 25 () 1 () 7 2,030 2,000 101 10 1. 2. 101 12 19 : 3 3. 98 5 12 123 1 4 4. 102 12 9 5.
26. 26. 26 103 3 21 103 5 2 103 7 4 103 8 15 103 9 10 9 29 6. () 1 () 3 4,012 9,000 1. 99 70% 105 8,000 3,500 2. 102 7,847 105 9,200 1 7,047 4,262
27. 27. 27 3. (1). 4,300 () 50 (2). I. ( ) 99 102 2 2,863 II. () i. 100 102 () 2,394 ( 2,185 ) ii. 4. 105 () 1 ()
28. 28. 28 2,470 4,000 1. 99 2. 101 7 102 8 81 23 7 19 32 (32 9 12 11 )102 3. 102 4. 15 8 4 5. 103
29. 29. 29 () 1 () 4,413 5,000 : 1. 2. 102 10 16 1021880851 11 26 103 1 9 103 2 26 1031860319 103 5 19 1030134437 3.
30. 30. 30 () 1 () 34 8,105 6,000 102 1. 26 90 103 56.6%( 56.5 24.51 ) 90 102 146 221 51.4% 2. 100 41.01% (45.54%)(47.13%) 3. 4. 102 10 18 1023280311 102 10 23 5.
31. 31. 31 () 3 () 5 0,235 7,000 1. 2. 102 11 29 103 2 14 103 3 3 103 7 1 3. () 104 7 1 103 7 1 102 103 3 3 103 7 1 4.
32. 32. 32 5. WTO/TBT WTO WTO 6. 7. () 3 () 11 0,694 7,000 1. 2. (1). (2).
33. 33. 33 (3). (4). 3. 11 (1). 102 2 (2). 102 1 (3). 103 8 4. () 3 () 9 4,199 3,000 BE 102 1. ( BE ) BE ()
34. 34. 34 2. (102) 3 28 12 30 / (103) 2 3. BE 46 92 GMP 4. () (http://www.fda.gov.tw/MLMS/(S(b3tk2045kqtdun55gp eyzi55))/H0001.aspx) 5. 12 31 () 3 () 1 1,521 7,000 1.
35. 35. 35 100 103 8 48 133 7,500 2. ( YAHOOPCHOME ) () 3. 4. - 5.
36. 36. 36 () 6 () 7,511 8,000 1. 20 1 () 101 () 101 7 16 2. 11 2
37. 37. 37 3. 102 (1). I. 96 II.99 III.102 3 IV. 103 103 2,500 (2). I. II. III. IV. V. 103 10 5,000
38. 38. 38 4. 5. 6. () 6 () ICF 1,439 2,000 1. 101 7 11 (WHO) (ICF)
39. 39. 39 103 (1). I. II. ( )( ) (2). I. II. ( ) 2.
40. 40. 40 () 6 () 2 7,125 1. 51 2. 101 3 102 2 7,000 101 3 2,370102 2 7,640 3. 4. 103 22
41. 41. 41 5. () 6 () 5 6,557 1,000 ( ) 1. 101 103 1 28 20 2. 103 7 24
42. 42. 42 104 40% 50% 60% 3. 40% 50% ( ) () 6 () 71 2,123 7,000 1. 0 2 2. 102 7 12 7
43. 43. 43 102 25 4,331 2 60% 3. 3 1,754 2,500 4. 103 2 13 5. 103 3 21 20% 20% 6.
44. 44. 44 () 6 () 1,414 4,000 1. 0 2 102 25 4,331 2 60.4% 2. 97 3. (1). 100 (2). 100 10 3
45. 45. 45 2 3,000 5,000 (3). 101 3,000 () 5,000 4,000 (4). 101 7 26 () 2,000 4,000 4. 3,000 5. 0 2 6. 103 12 1 100 ()
46. 46. 46 ( ) 17 () 103 9 15 7. () 6 () 13 6,215 2,000 1. 98 101 9 () 31 14 17 () 9 () 103 104 35 2. () 3.
47. 47. 47 () () () 4. ()( )( ) 5. 15 () 86 8 7 () 62.2% 6. ()()
48. 48. 48 103 () 104 7. () () ( ) () () 8. () () 6 () 1,414 4,000
49. 49. 49 1. 97 4 1 3,000 101 7 1 2. 103 12 1 0 2 0 2 3. 100 11 30 26 () ()
50. 50. 50 103 9 15 4. 103 12 1 () 103